Non-Helium Magnetoencephalography in Pediatric Brain Tumors

Launched by GUANGZHOU WOMEN AND CHILDREN'S MEDICAL CENTER · Apr 22, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a technique called magnetoencephalography (MEG) to see how well it works in assessing pediatric brain tumors before surgery. The goal is to find out if MEG can accurately locate these tumors and help doctors understand how much of the tumor can be safely removed, compared to traditional imaging methods like computed tomography (CT) and magnetic resonance imaging (MRI).

Children aged 3 to 18 who have been diagnosed with a brain tumor may be eligible to participate in this study. Participants will undergo both MEG and CT/MRI scans before their surgery to gather important information about their tumors. After the surgery, they will have follow-up scans and assessments at 1, 3, and 6 months to monitor their recovery and quality of life. It’s important to note that children with serious health conditions or certain neurological disorders may not be able to join the study. This trial is currently recruiting participants and aims to provide valuable insights that could improve the way brain tumors in children are treated.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age range: 3-18 years old;
• • Clinically diagnosed with brain tumor;
• • Capable of cooperating with magnetoencephalography evaluation and recording.
• Exclusion Criteria:
• • Patients with serious comorbidities or neurological or psychiatric disorders that affect magnetoencephalography examination.
• • Patients using drugs that affect central nervous system function;
• • Patients who are not suitable for surgical procedures;
• • Patients with progressive neurological disorders.